TEMPO.CO, Jakarta – The Indonesian government monitors the development of Deltacron variant of COVID-19, a combination of Delta and Omicron mutations that has been detected in Europe, the health ministry said.
“Its development is still being monitored. Because there is no evidence of an increase in transmission, severity and the like,” the COVID-19 vaccination spokeswoman told the Ministry of Health. Health, Siti Nadia Tarmizi, in a written statement received on Sunday.
Scientists had confirmed a new variant of COVID-19, which was a combination of the Omicron and Delta variants, with cases reported in several European countries.
The variant, dubbed “Deltacron”, was confirmed by genome sequencing carried out by scientists at the IHU Méditerranée Infection in Maseille, France. The variant has been detected in several regions of France.
According to the international database Global Initiative on Sharing All Influenza Data (GISAID), cases of the Deltacron variant have also been found in Denmark and the Netherlands.
Apart from these, two cases have been identified in the United States and 30 reported cases have been identified in the United Kingdom.
These variants were hybrids born through a process called recombination, in which two viral variants infect individuals simultaneously, resulting in an exchange of genetic material and creating new variants.
Tarmizi assured that the government continues to monitor the situation while promoting vaccination against COVID-19 to increase the vaccination rate.
“Yes, this means that in the face of any potential transmission, the dispatch of boosters and primary vaccinations must be (done),” she recalled.
An expert from YARSI University, Professor Tjandra Yoga Aditama, said that Deltacron is a combination of BA.1 and B.1617.2, and currently listed as a variant watch report.
He stated that Deltacron had been reported in Cyprus since 2021. However, many thought this virus was just dirt in the lab.
Read: Indonesia continues to record lower number of daily COVID-19 cases